Back to Search
Start Over
Phase I/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
- Source :
- International Journal of Radiation Oncology Biology Physics. 77(1):98-105
- Publication Year :
- 2009
-
Abstract
- PURPOSE: To evaluate the safety and efficacy of postoperative hyperfractionated concomitant boost proton radiotherapy with nimustine hydrochloride for supratentorial glioblastoma multiforme (GBM). METHODS AND MATERIALS: Twenty patients with histologically confirmed supratentorial GBM met the following criteria: (1) a Karnofsky performance status of >/=60; (2) the diameter of the enhanced area before radiotherapy was
Details
- Language :
- English
- ISSN :
- 03603016
- Volume :
- 77
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- International Journal of Radiation Oncology Biology Physics
- Accession number :
- edsair.jairo.........33c17eb6b4329673bbe33943dabb2ce2